Peter Lynch fit · Growth at a reasonable price (GARP)
Is Inspire Medical Systems, Inc. (INSP) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria — growth too low or price too high.
9/100
FNot a fit
3/6 criteria passed
Peter Lynch's Criteria, Applied to INSP
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key0.0%
Revenue CAGR ≥ 10%
3.0%
Net margin > 0
5.0%
Manageable debt (D/E < 1)
0.0x
Positive free cash flow
Yes
How INSP Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.18B
P/E (TTM)
9.1x
ROIC (TTM)
6.24%
Gross margin
85.78%
Other Peter Lynch fit reports
Frequently Asked Questions
What is INSP's Peter Lynch fit score?
INSP scores 9/100 on our Peter Lynch fit engine — grade F. Does not fit Lynch's GARP criteria — growth too low or price too high.
Does Peter Lynch actually own INSP?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends INSP.
How often is this score updated?
INSP's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends INSP.